Skip to main content

MoneyWorks4Me

Glenmark Pharma informs about press release

19 Jun 2018 Evaluate

Glenmark Pharmaceuticals has informed about press release titled ' The US FDA Approves First Supplemental Abbreviated New Drug Application (sANDA) for Glenmark Pharmaceuticals Manufacturing Facility in Monroe, North Carolina'.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..